In situ hybridization for human papillomavirus (HPV) messenger RNA (HPV RNA ISH) recently was introduced as an ancillary tool in the diagnosis of cervical squamous intraepithelial lesions, and can aid in the distinction between low-grade squamous intraepithelial lesions (LSILs) versus reactive/negative biopsies. Prior work has shown that up to one-half of cases originally diagnosed as LSIL are reclassified as negative/reactive by expert consensus review of morphology, and negative HPV RNA ISH results most often correlate with an expert diagnosis of negative/reactive. Given that LSIL overdiagnoses on biopsy may result in the erroneous clinical impression that a cervical lesion has been sampled appropriately, the authors proposed that HPV RNA ISH can inform cytology-histology correlation for challenging LSIL biopsies. METHODS: A total of 92 cervical biopsies originally diagnosed as LSIL were reviewed by 3 gynecologic pathologists and reclassified based on consensus opinion of morphology. ISH was performed for high-risk and low-risk HPV E6/ E7 mRNA. Prior/concurrent cytology results were collected. RESULTS: Based on expert consensus morphologic review, 49% of biopsies (45 of 92 biopsies) originally diagnosed as LSIL were reclassified as negative, 6.5% (6 of 92 biopsies) were reclassified as high-grade squamous intraepithelial lesion, and 44.5% (41 of 92 biopsies) were maintained as LSIL.
INTRODUCTION
The morphologic overlap between low-grade squamous intraepithelial lesions (LSILs, or cervical intraepithelial neoplasia grade 1 [CIN1]) and benign reactive cervical epithelium creates considerable diagnostic challenges for pathologists, as evidenced by the significant interobserver variability in this diagnosis [1] [2] [3] as well as pervasive LSIL overdiagnosis. 1, 3, 4 This high rate of LSIL overdiagnosis on biopsy has implications for cytology-histology correlation: a diagnosis of LSIL on biopsy after a Papanicolaou (Pap) test result of atypical squamous cells (ASC) or LSIL suggests continued disease and provides reassurance that the lesion has been sampled appropriately. Conversely, a negative biopsy after a high-risk human papillomavirus (HR-HPV)-positive ASC or LSIL biopsy suggests either complete resolution or raises the possibility of sampling error. Although the current American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines call for similar clinical follow-up in all iterations of these scenarios, 5 it is possible that risk could be better stratified with improved cytology-histology correlation for LSIL lesions.
Historically, ancillary studies were of little value in resolving a diagnosis of LSIL versus reactive lesions. For example, immunohistochemistry for p16 has proven unreliable in this context due to issues with both sensitivity and specificity. 2, [6] [7] [8] [9] [10] Methods based on the direct detection of HPV have demonstrated greater clinical usefulness, but to our knowledge the appropriate application of these studies is not well codified. [11] [12] [13] [14] However, in situ hybridization for HPV messenger RNA (HPV RNA ISH) has shown early promise in this setting. Past work using RNA ISH probes specific for the E6/E7 oncogenes from the 18 most common HR and 6 most common low-risk (LR) HPV types (RNAscope; Advanced Cell Diagnostics, Newark, California) has demonstrated excellent sensitivity and specificity in the detection of HPV on formalin-fixed, paraffinembedded tissue, with equal to improved sensitivity in comparison with other methods of detection, including p16 immunohistochemistry, HPV DNA ISH, and DNA polymerase chain reaction (PCR). [15] [16] [17] [18] Recent work from the study institution also has demonstrated that HPV RNA ISH can decrease the overdiagnosis of negative/reactive cases as LSIL and can help routine diagnoses approach expert morphologic consensus, the existent criterion standard for LSIL. 19 Furthermore, this study demonstrated that an expert-adjudicated standard can be improved by the judicious incorporation of HPV RNA ISH results. However, to the best of our knowledge, the role of HPV RNA ISH in refining cytology-histology correlation has not been investigated previously. In the current study, we reviewed cases originally diagnosed as LSIL from our prior series of HPV RNA ISH within the context of cytology results to investigate whether HPV RNA ISH results can improve cytology-histology correlation in a clinically significant manner.
MATERIALS AND METHODS
The current study was approved by the institutional review board of the University of Virginia. All LSIL biopsies were derived from a cohort already characterized for RNA ISH expression in a prior publication, 19 which described the methodology of the study. Briefly, the digital CoPath pathology information system (Cerner Corporation, North Kansas City, Missouri) records of the University of Virginia pathology department were searched for the most recent cervical biopsies diagnosed as cervical LSIL/CIN1, with approximately equal representation of all pathologists in the practice (approximately 10 cases per pathologist), including the gynecologic pathologists involved in the current study. The system was queried using a natural language search for cervical surgical biopsy specimens with the terms "LSIL" and/or "CIN1" in the final diagnosis. All cases were reviewed by 3 gynecologic pathologists (B.C.W., M.H.S., and A.M.M) and were reclassified based on consensus opinion of morphology as previously described, including multiheaded microscope adjudication for all controversial cases to arrive at a final morphologic consensus diagnosis. 19 Pathologists were blinded to con- 51, 52, 56, 58, 59, 66, and 68). PCR was directed against subtype-specific L1 targets approximately 200 base pairs in size. All specimens were run with a B-globin control (330 base pairs). HPV-16 and HPV-18 were identified specifically, and the other 12 HR-HPV types were identified collectively as "HR-HPV, other."
RESULTS
Based on expert consensus morphologic review, 49% of biopsies originally diagnosed as LSIL (45 of 92 biopsies) were reclassified as negative, 6.5% (6 of 92 biopsies) were reclassified as HSIL, and 44.5% (41 of 92 biopsies) were maintained as LSIL. The majority of LSIL biopsies reclassified as negative on review (80%; 36 of 45 biopsies) were HPV RNA negative, as were 7% of LSIL biopsies (3 of 41 biopsies) but 0% of HSIL biopsies (0 of 6 biopsies). 19 All positive HPV RNA results were observed with the highrisk probe, which included the 18 most common HR viral types; no cases in the current series demonstrated positivity for LR HPV RNA ISH.
The corresponding Bethesda System cytologic diagnoses and cytologic HPV DNA PCR results for the categories of expert consensus diagnosis of the LSIL biopsies are shown in Table 1 . Overall, 92% of cytologic LSIL cases (35 of 38 cases); 96% of ASC cases (25 of 26 cases); and 79% of atypical squamous cells, cannot rule out highgrade squamous intraepithelial lesion (ASC-H)/high-grade squamous intraepithelial lesion (HSIL) cases (22 of 28 cases) tested positive for HPV DNA by HPV PCR.
LSIL Cytology and LSIL Histology
Approximately 53% of cytologic LSIL biopsies (20 of 38 biopsies) were confirmed as LSIL on expert consensus morphologic review of the subsequent biopsy/conization specimens. Of those 20, all cases (100%) stained positive for HPV RNA.
LSIL Cytology and Negative Histology
Approximately 45% of cytologic LSIL biopsies (17 of 38 biopsies) were associated with negative histology by consensus morphologic review. Of those, 14 biopsies (82%) stained negative for HPV RNA, supporting the consensus opinion of negative. In the remaining 3 cases, a review of histology in concert with RNA ISH positivity suggested that LSIL was indeed the appropriate histologic diagnosis, as illustrated in Figure 1 . Correlation with cytology on these cases revealed more subtle LSIL with only occasional prototypical koilocytes and frequent ASC-type cells, providing strong correlation with the less overt features appreciated on histology.
ASC Cytology and LSIL Histology
Approximately 23% of cytologic ASC biopsies (6 of 26 biopsies) demonstrated expert-confirmed LSIL on the subsequent biopsy/conization specimens. Five of these were HPV DNA positive and one was HPV DNA negative. All 6 stained positive for HPV RNA, including the HPV DNA-negative case. This category included cases that were morphologically controversial, as depicted in Figure 2 . Correlation with cytology in this case revealed atypical cells that paralleled the morphology observed on biopsy, with irregular, hyperchromatic, enlarged nuclei and moderate to abundant associated cytoplasm but lacking well-formed koilocytic halos. 
ASC Cytology and HSIL Histology
Approximately 8% of the biopsy/conization specimens with correlating Bethesda System-classified ASC cytology (2 of 26 specimens) were termed HSIL on expert consensus morphologic review. Both specimens (100%) stained positive for HPV RNA. This included cases with a histologic differential diagnosis of squamous metaplasia versus HSIL/CIN2, as illustrated in Figure 3 . In this case, the strong HPV RNA reactivity noted throughout the epithelium supported the presence of an intraepithelial lesion rather than a metaplastic process. Correlation with the concurrent cytology revealed atypical cells with a low nuclearto-cytoplasmic (N/C) ratio, which was suggestive, but not diagnostic, of LSIL as well as clusters of cells with a higher N/C ratio that raised the possibility of a higher grade lesion and underscoring sampling and interpretive issues with Pap tests. When considered with the benefit of retrospect, the application of a p16 immunohistochemical stain to address the possibility of HSIL on biopsy would have been prudent in this case.
ASC Cytology and Negative Histology
Approximately 69% of the biopsy/conization specimens with correlating Bethesda System-classified ASC cytology (18 of 26 specimens) were termed negative on expert consensus morphologic review. All specimens were HPV DNA PCR positive (most likely a reflection of the fact that the positive DNA result triggered sampling in these cases). Approximately 78% (14 of 18 specimens) stained negative for HPV RNA, thereby supporting the negative read by morphology. This included cases such as that depicted in Figure 4 . This case demonstrated cytologically banal but heavily glycogenated epithelium on biopsy that was interpreted as LSIL at the time of the original diagnosis, but was considered to be negative on morphologic review. Review of cytology revealed legitimate ASC cells, including cells arranged in both clusters and cohesive groups, some of which had higher N/C ratios, thereby supporting a true cytology-histology discordance. It is interesting to note that these cells still do not meet the criteria for ASC-H or HSIL, and therefore cytology-histology correlation would not have been triggered in this case at the time of biopsy irrespective of whether the biopsy was termed negative or LSIL. A hysterectomy performed for benign leiomyomas 6 months later demonstrated HSIL.
ASC-H or HSIL Cytology and Negative Histology
Approximately 36% of the biopsy/conization specimens with correlating ASC-H/HSIL cytology (10 of 28 specimens) were termed negative on expert consensus morphologic review. Eight of these 10 specimens (80%) stained negative for HPV RNA. In these cases, the Pap result of ASC-H/HSIL overrode the biopsy result regardless of whether or not it was interpreted as negative or LSIL, because neither explains the presence of high-grade cells on cytology.
ASC-H or HSIL Cytology and LSIL Histology
Approximately 54% of the biopsy/conization specimens with correlating ASC-H/HSIL cytology (15 of 28 specimens) were classified as LSIL on morphologic review. Of these 15 specimens, 12 (80%) stained positive for HPV RNA.
ASC-H or HSIL Cytology and HSIL Histology
Approximately 11% of Bethesda System-classified ASC-H/ HSIL biopsies (3 of 28 biopsies) were termed HSIL on expert consensus morphologic review of the subsequent biopsy/conization specimens, all of which stained positive for HPV RNA.
DISCUSSION
Cytology-histology concordance means that the findings identified on biopsy explain the abnormal cells found on cytology. Concordance reviews serve as both a tool for retrospective education for cytotechnologists and cytopathologists as well as a prospective management tool for patients whose care is influenced by the cumulative risk predicted on cervical cytology and biopsy. The evaluation of cervical biopsies for intraepithelial lesions can involve 2 potential categories of harm: underdiagnosis and overdiagnosis. Underdiagnosis occurs in cases in which dysplastic lesions identified on cytology are missed on subsequent biopsy. This includes cytologic ASC-H/HSIL with a negative/reactive or LSIL biopsy diagnosis and cytologic ASC/ LSIL with a negative/reactive biopsy diagnosis. In the former instance, the ASCCP guidelines ensure that the cytology result of ASC-H or HSIL supplants the biopsy result, and further sampling remains indicated. 5 However, in the latter scenario, the lesion is presumed to be either resolved or unsampled but low-grade and therefore the patient is diverted to cytology HPV PCR cotesting at 12 months. This is potentially problematic for the minority of cases for which the ASC cells identified on cytology actually are representative of a high-grade process. This is illustrated in the case in Figure 3 , which depicts a biopsy (Fig. 3C) interpreted as negative/reactive by the consensus group until the HPV RNA ISH results were incorporated, at which point it was considered more consistent with CIN2. It is interesting to note that the cytology specimen, which was interpreted as ASC, included cells that were more suggestive of LSIL (as seen in Fig. 3A) , as well as cells with higher N/C ratios (seen in Fig. 3B ). This represents a case in which RNA ISH status could be additive to cytology correlation in the prevention of histologic underdiagnosis although, importantly, p16 IHC could serve the same function in this HSIL case. Conversely, the incorporation of HPV RNA ISH can confirm cytology-histology concordance for cytologic LSIL and ASC with morphologically challenging biopsies (as depicted in Figs. 1 and 2 ) and ensure appropriate monitoring for patients with ongoing LSIL diagnoses (vs presumed resolution of the lesion). It is interesting to note that p16 would not have been useful in these cases because the majority of LSIL cases are negative for p16. Overdiagnosis occurs when a negative/reactive biopsy is interpreted as LSIL, giving the false impression that a cytologically detected ASC or LSIL was identified and sampled. Such a case is illustrated in Figure 4 . HPV RNA ISH negativity resulted in a downgrading of the histology interpretation from LSIL to negative on expert consensus, thereby resulting in discordance with the preceding ASC cytology. In this case, subsequent HSIL was discovered incidentally at the time of hysterectomy for leiomyomas.
However, it is worth emphasizing that even if this cytology-histology discordance had been identified with the original diagnosis, further sampling would not be triggered by the existing guidelines, because the current ASCCP guidelines prescribe similar management for an ASC with HPV positivity followed by either a negative or an LSIL biopsy, namely repeat sampling with HPV PCR cotesting at 12 months.
There are several caveats to the current study that bear emphasis. First, diagnostic changes imparted on biopsies as a result of HPV RNA ISH results are unlikely to change the management of the majority of cases based on the current ASCCP guidelines because these guidelines already partially account for known interpretative variability with a decision algorithm that calls for repeat cytology at 12 months for ASC/LSIL cytology followed by either a negative or LSIL biopsy diagnosis. However, it is possible that such data could be of value in future iterations of the guidelines should this recommendation change. Second, the inconsistencies between the cytology and histology results are not exclusively attributable to interpretive and sampling errors: a subset of lesions will resolve between cytologic and biopsy sampling. This also is true for discrepancies in HPV status by cytology (by DNA PCR) versus biopsy (by RNA ISH). It is important to emphasize that because HPV DNA is not necessarily transcriptionally active, its presence does not always result in the generation of RNA. Furthermore, many of these discordances are likely attributable to sampling, because cytology specimens encompass a broader area of sampling than focal biopsies. Indeed, the argument that such discrepancies are attributable to sampling is bolstered by the prior work on this series, which demonstrated a strong correlation between HPV DNA PCR results from formalin-fixed, paraffinembedded biopsies and HPV RNA ISH performed on the same samples; in fact, HPV RNA ISH proved slightly more sensitive than HPV DNA PCR in this series, suggesting that false-negative HPV RNA ISH results are unlikely to account for discordant results. 15 Nonetheless, further specific studies evaluating cytology samples for both HPV DNA PCR and HPV RNA ISH may be warranted.
In the current study, we evaluated the role of HPV RNA ISH in honing cytology-histology correlation for biopsies with a possible LSIL diagnosis. These data suggest that judicious incorporation of HPV RNA ISH into the diagnostic workup can improve the accuracy of LSIL diagnosis on biopsy and improve cytology-histology correlation However, in situ hybridization for HPV messenger RNA performed as part of this study was found to be entirely negative, and on study review the morphologic biopsy diagnosis was changed to negative for an intraepithelial lesion. (A and B) Cytologic review confirmed the presence of legitimate ASC on the Papanicolaou specimen. (B) It is interesting to note that these included cells with an increased nuclear-to-cytoplasmic ratio, although these fell short of a diagnosis of atypical squamous cells, cannot rule out highgrade squamous intraepithelial lesion or high-grade squamous intraepithelial lesion (HSIL). Several months after the original cytology and biopsy interpretations, the patient underwent a hysterectomy for uterine fibroids and (E) incidental HSIL was identified. Note the increased nuclear-tocytoplasmic ratio, loss of appropriate maturation with the presence of these cells to the surface of the epithelium, and high-riding mitotic figure. This provided a histologic correlate for the cells observed on cytology.
by maximizing the identification of histologic underdiagnosis and overdiagnosis. Although this does not currently impact existing decision algorithms, it could be of use in clinical care as management recommendations undergo further refinement.
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